DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Dimethicone is an investigational drug.
There have been 5 clinical trials for Dimethicone. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2009.
The most common disease conditions in clinical trials are Radiodermatitis, Dermatitis, and Psoriasis. The leading clinical trial sponsors are University of British Columbia, G. Pohl-Boskamp GmbH & Co. KG, and Universitätsklinikum Hamburg-Eppendorf.
Recent Clinical Trials for Dimethicone
|Topical Menthol +/- Mannitol for Painful Diabetic Peripheral Neuropathy||University of British Columbia||Phase 1/Phase 2|
|Topical Use of Difinsa53™ to Prevent Radiation Dermatitis||Poudre Valley Health System||Phase 1/Phase 2|
|Topical Use of Difinsa53™ to Prevent Radiation Dermatitis||ProTechSure Scientific, Inc.||Phase 1/Phase 2|